ClinicalTrials.gov
ClinicalTrials.gov Menu

Study of Sorafenib, Gemcitabine, and Cisplatin in Advanced Hepatocellular Carcinoma (HCC)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00808145
Recruitment Status : Withdrawn (Lack of enrollment, many screen failures and non eligible study participants)
First Posted : December 15, 2008
Last Update Posted : October 22, 2014
Sponsor:
Information provided by (Responsible Party):
Lahey Clinic

No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Recruitment Status : Withdrawn
  Actual Primary Completion Date : October 2014
  Actual Study Completion Date : October 2014